Skip to main content

Table 1 Clinical characteristics of the two groups

From: Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study

  CCRT + E group
(n = 43)
CCRT group
(n = 45)
P value
Average age (range) 44.7 years (27–64) 43.6 years (24–66) 0.515
Sex    
 Men 29 (67.4%) 32 (71.1%) 0.709
 Women 14 (32.6%) 13 (28.9%)
Clinical stage (7th,UICC/AJCC)    0.955
 III 16 (37.2%) 15 (33.3%)
 IVa 22 (51.2%) 24 (53.3%)
 IVb 5 (11.6%) 6 (13.3%)
T stage    0.609
 T1 0 (0) 0 (0)
 T2 2 (4.7%) 5 (11.1%)
 T3 16 (37.2%) 15 (33.3%)
 T4 25 (58.1%) 25 (55.6%)
N stage    0.312
 N0 0 (0) 0 (0)
 N1 21 (48.8%) 28 (62.2%)
 N2 17 (39.5%) 11 (24.4%)
 N3 5 (11.6%) 6 (13.3%)
  1. CCRT, concurrent chemoradiotherapy; E, Endostar; T, primary tumor; N, regional lymph nodes